Prognosis of Failure Treatment of Amebic Liver Abscess

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

1999-05-31

Study Completion Date

2000-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Amebic liver abscess is the most frequent extra-intestinal form of the amoebiasis; actually the factors for predicting failure in the medical treatment are not clear. We conducted trial for determining the clinical value of paraclinical factor in this issue.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amebic Liver Abscess

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

amebic liver abscess failure prognosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Response to medical treatment

No interventions assigned to this group

2

Failure to medical treatment (surgery or percutaneous resolution)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Clinical, ultrasonographic and serologic diagnosis (ELISA) of amebic liver abscess.
2. Both genders
3. Older 15 years

Exclusion Criteria

1. Clinically suspected piogenous liver abscess
2. Positive hemoculture
3. Negative ELISA for amoebic antigens
4. Immunosupresion (HIV)
5. Abdominal or biliary surgery antecedents
6. Abdominal neoplasia antecedents

Minimum Eligible Age

16 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Epidemiologia Clinica, Universidad Autonoma de San Luis Potosí

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martín Sánchez-Aguilar 1, MSc

Role: PRINCIPAL_INVESTIGATOR

1. Department of Experimental Surgery, Faculty of Medicine, Universidad Autónoma de San Luis Potosí

Onofre Morán-Mendoza, PhD

Role: STUDY_DIRECTOR

Department of Clinical Epidemiology, Faculty of Medicine, Universidad Autónoma de San Luis Potosí

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Surgery, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán".

Mexico City, Mexico DF, Mexico

Site Status

Faculty of Medicine, Universidad Autónoma de San Luis Potosí

San Luis Potosí City, San Luis Potosí, Mexico

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Mexico

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PFP-ALA

Identifier Type: -

Identifier Source: org_study_id